DK1040185T3 - Neutrale forlöberceller, fremgangsmåde til fremstilling heraf og deres anvendelse til terapien af neurale defekter - Google Patents

Neutrale forlöberceller, fremgangsmåde til fremstilling heraf og deres anvendelse til terapien af neurale defekter

Info

Publication number
DK1040185T3
DK1040185T3 DK98966817T DK98966817T DK1040185T3 DK 1040185 T3 DK1040185 T3 DK 1040185T3 DK 98966817 T DK98966817 T DK 98966817T DK 98966817 T DK98966817 T DK 98966817T DK 1040185 T3 DK1040185 T3 DK 1040185T3
Authority
DK
Denmark
Prior art keywords
progenitor cells
cells
neural progenitor
serum
growth factor
Prior art date
Application number
DK98966817T
Other languages
Danish (da)
English (en)
Inventor
Oliver Prof Dr Bruestle
Original Assignee
Oliver Prof Dr Bruestle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7852738&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1040185(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oliver Prof Dr Bruestle filed Critical Oliver Prof Dr Bruestle
Application granted granted Critical
Publication of DK1040185T3 publication Critical patent/DK1040185T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK98966817T 1997-12-19 1998-12-18 Neutrale forlöberceller, fremgangsmåde til fremstilling heraf og deres anvendelse til terapien af neurale defekter DK1040185T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19756864.5A DE19756864C5 (de) 1997-12-19 1997-12-19 Neurale Vorläuferzellen, Verfahren zu ihrer Herstellung und ihre Verwendung zur Therapie von neuralen Defekten

Publications (1)

Publication Number Publication Date
DK1040185T3 true DK1040185T3 (da) 2006-07-03

Family

ID=7852738

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98966817T DK1040185T3 (da) 1997-12-19 1998-12-18 Neutrale forlöberceller, fremgangsmåde til fremstilling heraf og deres anvendelse til terapien af neurale defekter

Country Status (11)

Country Link
US (1) US7968337B2 (fr)
EP (2) EP1637592A1 (fr)
JP (1) JP4090692B2 (fr)
AT (1) ATE318301T1 (fr)
AU (1) AU755028B2 (fr)
CA (1) CA2315538C (fr)
DE (2) DE19756864C5 (fr)
DK (1) DK1040185T3 (fr)
ES (1) ES2259220T3 (fr)
IL (2) IL136833A0 (fr)
WO (1) WO1999032606A2 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19756864C5 (de) 1997-12-19 2014-07-10 Oliver Brüstle Neurale Vorläuferzellen, Verfahren zu ihrer Herstellung und ihre Verwendung zur Therapie von neuralen Defekten
IL129966A (en) * 1999-05-14 2009-12-24 Technion Res & Dev Foundation ISOLATED HUMAN EMBRYOID BODIES (hEB) DERIVED FROM HUMAN EMBRYONIC STEM CELLS
AU2005202789B2 (en) * 1999-05-14 2007-04-05 Technion Research And Development Foundation Ltd. Differentiated human embryoid cells and a method for producing them
CA2377906A1 (fr) * 1999-07-16 2001-01-25 Prescient Neuropharma Inc. Methodes de production et de preparation de cellules pour une therapie cellulaire
CA2397292A1 (fr) * 2000-01-14 2001-07-19 Bresagen Limited Production de cellules
US6602711B1 (en) * 2000-02-21 2003-08-05 Wisconsin Alumni Research Foundation Method of making embryoid bodies from primate embryonic stem cells
US7439064B2 (en) 2000-03-09 2008-10-21 Wicell Research Institute, Inc. Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium
US7005252B1 (en) * 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
US7011828B2 (en) * 2000-03-14 2006-03-14 Es Cell International Pte. Ltd. Implanting neural progenitor cells derived for human embryonic stem cells
AU2005200148B2 (en) * 2000-03-14 2007-12-20 Es Cell International Pte Ltd Embryonic stem cells and neural progenitor cells derived therefrom
WO2001068815A1 (fr) * 2000-03-14 2001-09-20 Es Cell International Pte Ltd Cellules embryonnaires et cellules souches neuronales derivees de celles-ci
WO2001083715A2 (fr) * 2000-05-01 2001-11-08 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary, Derivation de neurones dopaminergiques du mesencephale de cellules souches embryonnaires
US7250294B2 (en) * 2000-05-17 2007-07-31 Geron Corporation Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
WO2001088104A2 (fr) 2000-05-17 2001-11-22 Geron Corporation Populations de progeniteurs neuronaux
JP2004504834A (ja) 2000-08-01 2004-02-19 イスム　リサーチ　ディベロップメント　カンパニー 胚性細胞の定方向分化
WO2002026941A2 (fr) * 2000-09-29 2002-04-04 Kooy Derek V D Cellules nerveuses embryonnaires primitives et procede de differenciation de cellules embryonnaires par rapport a des cellules nerveuses
CA2364095C (fr) * 2001-07-20 2011-07-12 Neurostasis, Inc Production de cellules gliales radiales
US8153424B2 (en) 2001-10-03 2012-04-10 Wisconsin Alumni Research Foundation Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells
US7588937B2 (en) 2001-10-03 2009-09-15 Wisconsin Alumni Research Foundation Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells
WO2003038075A1 (fr) * 2001-10-30 2003-05-08 Renomedix Institute Inc. Procede permettant d'induire une differenciation de cellules souches embroyonnaires mesodermiques, de cellules es ou de cellules immortalisees dans des cellules du systeme nerveux
US20060281179A1 (en) * 2001-11-15 2006-12-14 Yoshiki Sasai Inducer for differentiation of embryo stem cells into ectodermal cells method of obtaining the same and use thereof
AU2003202988A1 (en) 2002-01-14 2003-07-30 The Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
WO2004015077A2 (fr) * 2002-08-08 2004-02-19 University Of Georgia Research Foundation, Inc. Compositions et methodes de differentiation neuronale de cellules souches embryonnaires humaines
ATE492636T1 (de) 2002-10-22 2011-01-15 Eisai R&D Man Co Ltd Spezifisch in postmitotischen dopamin- produzierenden neuronalen vorläuferzellen exprimiertes gen
BRPI0408733A (pt) * 2003-03-12 2006-03-07 Reliance Life Sciences Pvt Ltd derivação de neurÈnios dopaminérgicos terminalmente diferenciados de células tronco embriÈnicas humanas
US8617887B2 (en) * 2003-06-12 2013-12-31 Yeda Research And Development Co. Ltd Method of generating oligodendrocytes from neurosphere cells
NZ551832A (en) * 2004-06-09 2010-01-29 Univ Edinburgh Neural stem cells
WO2005123902A1 (fr) * 2004-06-18 2005-12-29 Riken Méthode pour induire la différenciation de cellules souches embryonnaires en nerf à l'aide d'une culture en suspension exempte de sérum
KR100838013B1 (ko) * 2006-06-07 2008-06-12 제일약품주식회사 인간배아줄기세포로부터 단계적 선별법을 통해 고수율로신경전구세포, 신경세포 및 기능성 도파민신경세포를생성하는 방법
EP3187581A1 (fr) 2008-12-23 2017-07-05 BOCO Silicon Valley, Inc. Populations cibles de cellules précurseurs d'oligodendrocytes et leurs procédés de fabrication et d'utilisation
JP5783504B2 (ja) * 2009-03-30 2015-09-24 国立研究開発法人国立環境研究所 胎生プログラミングに対する影響を評価するための方法
MX364742B (es) * 2011-01-12 2019-05-07 Tsuneo Kido Metodo de cultivo para obtener y mantener una poblacion pura o enriquecida de celulas no diferenciadas neurales y/o celulas progenitoras neurales de mamifero que con propensas a diferenciarse en celulas del linaje oligodendrocitico in vitro.
US20170296595A1 (en) 2014-09-18 2017-10-19 North Carolina State University Mammalian Lung Spheroids and Lung Spheroid Cells and Uses Thereof
DE102014018663A1 (de) 2014-12-13 2015-03-05 Heinz Kiefer Nachweis von vermehrungsfähigen Zellen zur Überprüfung von Arzneimittel-Wirkstoffangaben bei Zulassungsverfahren
EP3237605B1 (fr) * 2014-12-24 2021-02-24 Neuorphan Pty Ltd. Améliorations de procédés de culture d'oligodendrocytes et de méthodes de traitement de troubles neurodégénératifs à l'aide d'hormones thyroïdiennes ou analogues
AU2017290805B2 (en) 2016-07-01 2023-11-16 Research Development Foundation Elimination of proliferating cells from stem cell-derived grafts
CN115873796B (zh) * 2021-09-29 2024-05-14 中国科学院动物研究所 一种神经细胞组合和其应用
CN113913383A (zh) * 2021-10-08 2022-01-11 山东万海生物科技有限公司 一种胚胎神经干细胞体外培养基及培养方法
CN113846060B (zh) * 2021-10-29 2024-04-19 上海市同济医院 一种纳米材料在促进胚胎干细胞向神经前体细胞分化中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980885A (en) * 1991-07-08 1999-11-09 Neurospheres Holdings Ltd. Growth factor-induced proliferation of neural precursor cells in vivo
US6432711B1 (en) * 1993-11-03 2002-08-13 Diacrin, Inc. Embryonic stem cells capable of differentiating into desired cell lines
US5753505A (en) * 1995-07-06 1998-05-19 Emory University Neuronal progenitor cells and uses thereof
IL124005A (en) * 1995-11-01 2004-06-20 Genentech Inc Normal neural epithelial precursor cells
DE19756864C5 (de) 1997-12-19 2014-07-10 Oliver Brüstle Neurale Vorläuferzellen, Verfahren zu ihrer Herstellung und ihre Verwendung zur Therapie von neuralen Defekten
US7629169B2 (en) * 2004-12-01 2009-12-08 Stem Cell Therapeutics Corp. Methods for the production of platelet-derived growth factor-responsive neural precursor cells

Also Published As

Publication number Publication date
EP1040185B9 (fr) 2006-06-28
AU2510699A (en) 1999-07-12
DE19756864C1 (de) 1999-04-29
ES2259220T3 (es) 2006-09-16
DE19756864C5 (de) 2014-07-10
CA2315538A1 (fr) 1999-07-01
DE59813404D1 (de) 2006-04-27
CA2315538C (fr) 2012-07-24
JP2001526884A (ja) 2001-12-25
US20080213888A1 (en) 2008-09-04
EP1040185A2 (fr) 2000-10-04
EP1637592A1 (fr) 2006-03-22
ATE318301T1 (de) 2006-03-15
JP4090692B2 (ja) 2008-05-28
IL136833A0 (en) 2001-06-14
WO1999032606A3 (fr) 1999-08-26
AU755028B2 (en) 2002-11-28
EP1040185B1 (fr) 2006-02-22
IL136833A (en) 2007-06-03
EP1040185B2 (fr) 2018-02-28
US7968337B2 (en) 2011-06-28
WO1999032606A2 (fr) 1999-07-01

Similar Documents

Publication Publication Date Title
DK1040185T3 (da) Neutrale forlöberceller, fremgangsmåde til fremstilling heraf og deres anvendelse til terapien af neurale defekter
Magyar et al. Mass production of embryoid bodies in microbeads
CA2443151C (fr) Procede de production de cellules souches de nerfs, de neurones moteurs et de neurones gabaergiques a partir de cellules souches d'embryons
DE60017875D1 (de) Verwendung von collagenase in der zubereitung von neuralen stammzellkulturen
EP1298202A3 (fr) Facteurs biologiques et cellules souches neurales
NO951378D0 (no) Remyelinering ved anvendelse av neural stamceller
ATE270323T1 (de) Zusammensetzungen und verfahren zur stimulierung der proliferation und der differenzierung von menschlichen fetalen und erwachsenen pankreatischen zellen ex vivo
WO2003038076A1 (fr) Cellules mesenchymateuses immortalisees et leur utilisation
CA2174746A1 (fr) Cellules souches embryonnaires capables de se differencier en lignees cellulaires desirees
WO2001021767A3 (fr) Cellules souches embryonnaires totipotentes
ES2108287T3 (es) Metodo para producir aglutinantes resistentes al desgaste por frotamiento para catalizadores.
DK1097988T3 (da) Fremgangsmåde til celledyrkning i monolag
WO2004090096A3 (fr) Procedes de differenciation neuronale de cellules souches embryonnaires au moyen de techniques de passage de protease
ATE153214T1 (de) Medien zur zellzucht und verfahren dazu
DE69723855D1 (de) Verfahren zur herstellung von polypeptiden in surfaktinmutanten von bacillus zellen
DK1218489T3 (da) Pluripotente embryonlignende stamceller, præparater, fremgangsmåder og anvendelse deraf
WO1999029279A3 (fr) Survie a long terme et regeneration de neurones du systeme nerveux central
EP0202667A3 (fr) Méthode de régénération de plant de riz à partir de protoplastes
DE69034128D1 (de) Saccharose-Phosphat-Synthase (SPS), ihr Verfahren zur Herstellung, ihr cDNA und Verwendung von cDNA zur Veränderung der SPS-Expression in Pflanzenzellen
WO1998036636A3 (fr) Procede de production de cultures cellulaires embryogenes pour la production de bananes transgeniques (de l'espece musa)
ATE168720T1 (de) Sukrosephosphatsynthase (sps), verfahren zu ihrer herstellung, ihre c-dns, und verwendung der c-dns zur modifizierung der sps-expression in pflanzenzellen
Doljanski et al. Studies on Rous sarcoma cells cultivated in vitro. I. Cellular composition of pure cultures of Rous sarcoma cells
JPS6427493A (en) Production of protein containing nonnatural-type amino acid
CN100519741C (zh) 动物卵细胞提取物
DE50012777D1 (de) VERFAHREN ZUR Herstellung von Neuronalem Zellmaterial